Bone Solutions Gains FDA Clearance for Mg OSTEOREVIVE Spine Magnesium-Based Bone Void Filler

Bone Solutions received FDA 510(k) clearance to market Mg OSTEOREVIVE, a magnesium-based injectable and moldable bone void filler indicated for posterolateral spine fusion procedures.

The efficacy of magnesium was a key component of BSI’s approach to developing the Mg OSTEOREVIVE technology. A critical component for bone health and development,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us